Hans Bishop vs Scott Carmer | Comparably
Comparably
Profile Image
VS
Juno Therapeutics Claimed Company
EMPLOYEE
PARTICIPANTS
6
TOTAL
RATINGS
165
NexImmune Claimed Company
EMPLOYEE
PARTICIPANTS
16
TOTAL
RATINGS
213

Hans Bishop vs Scott Carmer

Hans Bishop Juno Therapeutics' CEO
Hans Bishop
Juno Therapeutics
Top 5%
Top 5% of Similar Size Companies on Comparably
A+
86/100
VS
Scott Carmer NexImmune's CEO
Scott Carmer
NexImmune
Bottom 45%
Bottom 45% of Similar Size Companies on Comparably
C
70/100

Juno Therapeutics vs NexImmune CEO Comparison Summary

Employees at Juno Therapeutics rank Hans Bishop in the Top 5% of CEOs in Seattle. Comparatively, employees at NexImmune rank Scott Carmer in the Top 40% of CEOs in Washington, DC. Employees rate their CEO differently based on the frequency of interaction, ability to affect company culture, and drive measurable results.

Question:
Do you approve of your CEOs management style?

Hans Bishop Juno Therapeutics' CEO
Hans Bishop
Juno Therapeutics
Yes
100%
No
0%
Scott Carmer NexImmune's CEO
Scott Carmer
NexImmune
N/A

Not Enough Data

Who Ranks the CEO highest?

Hans Bishop Juno Therapeutics' CEO
Hans Bishop
Juno Therapeutics
88/100Ethnicity - Caucasian
Education - N/A
83/100Experience - Over 10 Years
Scott Carmer NexImmune's CEO
Scott Carmer
NexImmune
Ethnicity - N/A
Education - N/A
80/100Experience - Over 10 Years

View Similar Size Companies and Their Competitors in Seattle